Find your path to Jim
59 people in our graph share verified history with Jim — schools, employers, funds. One of them is your warm intro.
Bridget Martell MA, MDunlockedJim: together at Aligos Therapeutics (2026)
Jim: together at Aligos Therapeutics
×2Jim: together at Coherus Biosciences
×6Jim: together at Nova Southeastern University
EVP, Chief Commercial Officer at Aligos Therapeutics
Intro paths
→
In turn, Jim can intro founders to Aligos Therapeutics's investors below.
Aligos Therapeutics's investors · 3
Co-founders at Aligos Therapeutics
LB
Leonid BeigelmanPresident
LM
Lawrence M. BlattChairman, President & CEO (Co-founder)
Experience
- Aligos TherapeuticsChief Commercial Officercurrent2026 — presentSouth San Franciso
- Geron CorporationSenior Vice President, Sales & Marketing2024 — 2025United States
- Crinetics PharmaceuticalsChief Commercial Officer2022 — 2024San Diego, California, United States
- Arrowhead PharmaceuticalsChief Commercial Officer & Business Development Lead2020 — 2021Pasadena, California
- Coherus BioSciencesSenior Vice President, Marketing & Market Access2016 — 2020San Francisco Bay Area
Skills & more
Change ManagementSales & Marketing Leadership
Languages English · French
From Jim's professional profile.
Frequently asked questions
- Who is Jim Hassard?
- EVP, Chief Commercial Officer at Aligos Therapeutics
- Where does Jim Hassard work?
- Jim Hassard is EVP, Chief Commercial Officer at Aligos Therapeutics.
- Where did Jim Hassard go to school?
- Jim Hassard studied at University of Toronto (B.Sc.(Hons), Pharmacology); Nova Southeastern University (Master of Business Administration (MBA)).
Same school
Also attended University of Toronto726
Ilya SutskeverCo-founder of OpenAI; co-founder & CEO of Safe SuperintelligenceNick FrosstCo-founder of CohereYasmin RazaviInvestor at Spark CapitalImran BashirFounding Partner, Chief Operating Officer at Extreme Venture PartnersKarim GillaniGeneral Partner at Luge CapitalAndrew MiklasGeneral Partner at Y Combinator
+ 720 more
Also attended Nova Southeastern University36
Catherine Pearce, DHSc, MBAAdvisor at CincyTechGanesh PersadVice President & Chief Information Officer at Flare Capital PartnersDayakar PuskoorFounder and Managing Director at Dallas Venture CapitalDavid G. AlexanderVice Chairman and Managing Director at Third Eye CapitalDr. David G. AlexanderVice-Chairman and Managing Director at Third Eye CapitalErin DeeLender Member Board Member at The Mortgage Collaborative
+ 30 more
Shared employers
Also worked at Aligos Therapeutics9
Bridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalJack NielsenManaging Partner at Vivo CapitalPierre RaboissonChief Executive Officer Chief Scientific Officer Co-founder at CoultreonFrançois GonzalvezCo-founder at CoultreonSandrine VendevilleCo-founder at CoultreonHardean AchneckExecutive Officer at Aligos Therapeutics
+ 3 more
Also worked at Geron Corporation8
Joyce BremerInvestor at True VenturesMelissa LezametaAssociate at Epidarex CapitalDaniel BradburyInvestor at BioBritNam KimExecutive Officer, Director at KDx DiagnosticsCatherine PriestChief Development Officer at Neurona TherapeuticsMichelle J. RobertsonExecutive Vice President, Chief Financial Officer, Treasurer and Interim Secretary at Geron
+ 2 more
Also worked at Crinetics Pharmaceuticals6
David AllisonManaging Director at Westlake Village BioPartnersJack NielsenManaging Partner at Vivo CapitalStephen F. BetzExecutive Officer at Crinetics Pharmaceuticals, Inc.R. Scott StruthersPresident, Chief Executive Officer and Director at CrineticsTobin SchilkeChief Financial Officer at CrineticsIsabel KalofonosChief Commercial Officer at Crinetics
